After Waller's hawkish comments, Goldman Sachs raises rate hike expectations: May raise rates two more times, with a 25 basis point increase in December
Goldman Sachs Chief Economist Jan Hatzius stated that the Federal Reserve might opt to raise interest rates two more times, rather than only once in December.
Zhitong Finance APP has learned that after Federal Reserve Governor Christopher Waller delivered a hawkish speech at the Central Bank Forum in Istanbul, Turkey, Goldman Sachs Chief Economist Jan Hatzius stated that the Federal Reserve may choose to raise rates two more times, rather than only once in December.
In a report, Hatzius said that it may be more appropriate to raise rates twice, and the probability of only one rate hike in December has decreased. The analyst noted that Waller’s speech signaled his stance has shifted from previously emphasizing the three-month annualized rate of core PCE inflation to a more hawkish position. However, Goldman Sachs still expects the Federal Reserve to raise rates by 25 basis points in December.
What did Waller say?
Waller’s remarks on Thursday suggested that it may be necessary to further raise interest rates in order to contain rising inflation and bring it back down to the Federal Reserve’s 2% target. He also added that there is “flexibility” in the pace of rate hikes.
In his prepared remarks, Waller stated: “If economic data continues to evolve as expected, I anticipate further rate hikes to support a timelier return of inflation to our 2% target.”
“But there is some flexibility regarding the timing of these rate hikes. Additional rate increases do not have to occur at consecutive meetings but should be implemented within an acceptable period.”
These comments were made shortly after the Federal Open Market Committee (FOMC) meeting minutes were released. The minutes show that 19 Federal Reserve officials supported a rate hike in September.
In September, the Federal Reserve raised the benchmark rate by 25 basis points to a target range of 3.75%-4%, the first rate hike in about three years. Dot plot forecasts indicate that most Federal Reserve officials expect another 25 basis point hike before the end of the year.
According to data from CME's FedWatch tool, the probability of a 25 basis point rate hike in October is 17.7%, while the probability of a cumulative hike of up to 50 basis points by December is 83.7%.
Multiple macro catalysts point to imminent rate hikes
Waller also stressed that although the Iran war has caused shocks in energy prices and the AI-driven debt expansion has sparked new concerns about inflationary pressures, with a strengthening economy, the reasons for rate hikes are now clear.
Waller said: “There is evidence that economic activity is picking up in the second half of this year. I am not particularly concerned that tightening monetary policy will trigger a damaging economic slowdown. But I do worry that the recent acceleration of inflation... will lead consumers, investors, and firms setting prices to raise their expectations for future inflation.”
He pointed out that policymakers will send signals about the direction of interest rates, adding: “These signals help anchor the short-term interest rate path, while also providing flexibility to adjust rate hikes based on newly released data.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese Yen: Choppy trade inside defined range – UOB
BUZZ—U.S. Stock Market Update—SpaceX, Humana, Crescent Energy
Query string for tracking individual stock trends: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Briefing": https://refini.tv/3dKUyB8 Reuters, October 9 – On Friday, U.S. stock indices are expected to open higher, boosted by falling oil prices as concerns over Middle East supply ease, although telecom stocks remain under pressure amid worries of increased industry-wide competition following SpaceX's spectrum acquisition. ** T-Mobile US Inc TMUS.O: In Discussion – European telecom stocks fell after SpaceX's spectrum deal nL6N45V0EH ** SpaceX SPCX.O: In Focus – Shares rose after reaching an agreement to acquire a nationwide low-band spectrum portfolio nL4N45V0KP ** Humana Inc HUM.N: In Focus – Shares rose on the back of an upgraded rating for its “Federal Medicare Advantage Plan” [nL4N45V0LU ** Definium Therapeutics Inc DFTX.O: Market Watch – Stock rose after JPMorgan rated its LSD-based therapies as “Overweight” nL4N45V0NH ** UnitedHealth Group Inc UNH.N: Market Update – TD Cowen lowered its price target ahead of UnitedHealth’s Q3 financials nL4N45V0OU ** Newmont Corporation NEM.N: ** Gold Fields Ltd GFI.N: ** Harmony Gold Mining Company HMY.N: ** AngloGold Ashanti AU.N: Market Update – Gold miner stocks rose modestly as gold prices moved up on weaker dollar nL4N45V0PG ** Delta Air Lines DAL.N: Market Flash – Shares dropped after sharply cutting its full-year profit guidance nL4N45V0RA ** Apple AAPL.O: In Focus – Shares fell on reports of iPhone production cuts nL4N45V0SB ** Crescent Energy CRGY.N: Market Update – Shares dropped after it raised $1 billion to acquire Devon Energy nL6N45V0J4 ** Medtronic MDT.N: ** Tandem Diabetes Care Inc TNDM.O: ** PROCEPT BioRobotics Corp PRCT.O: ** Insulet Corporation PODD.O: Market Update – Leerink says industry-wide growth concerns for med-tech may outweigh Q3 results nL4N45V0YE (For the convenience of non-English speakers, Reuters automates translation of its reports into several languages. Because automated translations may contain errors or fail to capture the intended context, Reuters does not guarantee the accuracy of these texts and provides them solely for reader convenience. Reuters assumes no liability for any damages or losses resulting from the use of automated translation features.)
BUZZ - Leerink says concerns over growth in the medical technology sector may overshadow third-quarter performance
October 9 – Leerink Partners stated that, ahead of the third-quarter earnings reports, it remains cautious on the medical technology sector and pointed out that the short-term market environment is “somewhat uncertain.” The firm noted increasing competition in some markets, including the cardiac devices and diabetes care sectors; uncertainty in surgical volumes amid rising costs; weak consumer confidence; and pressure on hospital budgets due to higher interest rates. “We believe that even if third-quarter results are positive, they may be overshadowed by ongoing market concerns about profitability and growth prospects for 2027 and beyond,” the broker said. The firm believes that positive factors for specific companies could help Medtronic (MDT.N) and Tandem Diabetes Care (TNDM.O) outperform the broader industry during these sector-wide headwinds. The broker said it remains most cautious on PROCEPT BioRobotics (PRCT.O) and Insulet (PODD.O), as a slowdown in adoption and intensifying competition may lead to lowered expectations for 2027. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translation may contain errors or fail to capture the required context, Reuters does not guarantee the accuracy of automated translation texts, and they are provided merely for readers’ convenience. Reuters accepts no liability for any damage or loss resulting from the use of automated translation features.)
EUR/USD Price Forecast: Rallies fail above 1.1200 amid high Oil prices, debt woes
Crypto prices
More
